Radiotherapy Patient Positioning Devices Market Size, Share, Growth and Industry Analysis, By Types (Immobilization Systems, Cushions, Thermoplastic Masks and Sheet, Other), By Applications (Hospitals, Radiation Therapy Centers, Other), Regional Insights and Forecast to 2034

Radiotherapy Patient Positioning Devices Market Size

As per Global Growth Insights, the Radiotherapy Patient Positioning Devices Market was valued at USD 223.48 Million in 2024 and is projected to reach USD 248.42 Million in 2025, USD 276.14 Million in 2026, and USD 643.75 Million by 2034, registering a CAGR of 11.16% during the forecast period 2025–2034. The market growth is driven by the increasing adoption of precision-based oncology treatments and the need for accurate patient immobilization during radiotherapy procedures. Over 60% of global radiotherapy treatments rely on advanced positioning devices to ensure treatment accuracy and safety. Approximately 38% of oncology centers are incorporating robotic-assisted positioning systems to enhance repeatability and workflow efficiency, while 45% are prioritizing thermoplastic mask technologies for head and neck cancer treatment, reflecting the rising focus on patient comfort, targeting precision, and improved clinical outcomes in modern radiotherapy practices.

The US Radiotherapy Patient Positioning Devices Market demonstrates significant growth, accounting for over 17% of the global share in 2025. Nearly 55% of US hospitals use advanced immobilization systems, while 42% of oncology centers rely on AI-based alignment for treatment accuracy. The adoption of patient comfort-driven devices has grown by 28%, ensuring higher compliance rates across radiotherapy procedures and highlighting the region’s focus on advanced treatment infrastructure.

Key Findings

• Market Size: Valued at USD 223.48 Million in 2024, projected to touch USD 248.42 Million in 2025 to USD 643.75 Million by 2034 at a CAGR of 11.16%.
• Growth Drivers: Over 60% treatments depend on precision devices, 45% hospitals adopt thermoplastic masks, 38% integrate robotic positioning globally.
• Trends: Nearly 42% of new oncology centers use AI-alignment, 35% focus on patient comfort, 28% reduce repositioning errors with hybrid systems.
• Key Players: CIVCO Radiotherapy, Klarity, Orfit Industries, Elekta, Qfix & more.
• Regional Insights: Asia-Pacific holds 30% share driven by rising cancer cases and advanced infrastructure. North America captures 32% with strong oncology adoption. Europe accounts for 25% supported by healthcare investments. Middle East & Africa represents 13% with expanding specialized treatment centers.
• Challenges: Around 40% smaller centers face cost barriers, 32% report workforce shortages, 28% link errors to inadequate operator training.
• Industry Impact: Nearly 55% of investments target hospitals, 30% radiation therapy centers, 28% focus on thermoplastic masks enhancing treatment efficiency.
• Recent Developments: 33% new products are thermoplastic masks, 29% robotic systems, 36% imaging-integrated devices, 31% eco-friendly accessories introduced.

The Radiotherapy Patient Positioning Devices Market is evolving rapidly with increased focus on precision, patient comfort, and eco-friendly solutions. Over 48% of emerging economies are investing heavily in oncology infrastructure, while 37% of global innovation efforts target AI integration for better treatment alignment, reshaping radiotherapy practices worldwide.

Radiotherapy Patient Positioning Devices Market Trends

The radiotherapy patient positioning devices market is experiencing rapid growth driven by rising cancer prevalence and technological advancements in treatment precision. Over 60% of oncology treatments now require advanced patient positioning devices to enhance accuracy and minimize radiation exposure to healthy tissues. Nearly 45% of hospitals and cancer centers worldwide have already integrated robotic positioning systems for radiotherapy. Furthermore, 35% of global installations are adopting image-guided positioning solutions, enabling real-time accuracy. Demand for immobilization masks and cushions is increasing at 40% due to improved patient comfort and reduced movement during procedures. Asia-Pacific accounts for more than 38% of device adoption, followed by North America with 30% share, highlighting regional expansion in advanced radiotherapy solutions.

Radiotherapy Patient Positioning Devices Market Dynamics

OPPORTUNITY

Expansion of Radiotherapy Centers

Nearly 55% of new oncology facilities globally are investing in patient positioning devices to enhance radiotherapy efficiency. Around 42% of investments focus on advanced positioning systems such as robotic couches and immobilization equipment to improve precision.

DRIVERS

Growing Cancer Burden

Over 65% of cancer cases require radiotherapy, with 50% of treatments demanding advanced positioning accuracy. Patient positioning devices contribute to a 30% reduction in radiation misalignment, supporting widespread adoption across oncology care facilities.

RESTRAINTS

"High Equipment Costs"

More than 40% of small healthcare providers face budget constraints in acquiring advanced positioning devices. Around 35% of institutions report cost as the primary barrier, limiting adoption in low and middle-income regions despite rising treatment needs.

CHALLENGE

"Skilled Workforce Shortage"

Nearly 32% of healthcare facilities highlight a shortage of trained professionals to operate advanced radiotherapy positioning devices. Around 28% of treatment errors are linked to inadequate expertise, creating challenges in ensuring accuracy and patient safety.

Segmentation Analysis

The global radiotherapy patient positioning devices market was USD 223.48 Million in 2024 and is projected to reach USD 248.42 Million in 2025, further expanding to USD 643.75 Million by 2034 at a CAGR of 11.16%. By type, immobilization systems, cushions, thermoplastic masks and sheets, and other supportive accessories dominate. Immobilization systems accounted for the largest market share in 2025, with thermoplastic masks showing the fastest CAGR growth, while cushions and other devices provide significant support across oncology centers. Each segment demonstrates unique adoption trends with precise share, CAGR, and regional dominance.

By Type

Immobilization Systems

Immobilization systems are widely used in radiotherapy to ensure precise patient positioning and reduce treatment errors. Around 55% of oncology facilities globally rely on advanced immobilization devices to enhance accuracy and minimize radiation exposure to healthy tissue. The adoption is strongest in developed healthcare infrastructures where treatment precision is critical.

Immobilization Systems held the largest share in the radiotherapy patient positioning devices market, accounting for USD 96.54 Million in 2025, representing 38.8% of the total market. This segment is expected to grow at a CAGR of 10.9% from 2025 to 2034, driven by increased oncology treatment needs and advancements in robotic positioning.

Top 3 Major Dominant Countries in the Immobilization Systems Segment

• United States led the Immobilization Systems segment with a market size of USD 28.45 Million in 2025, holding an 11.4% share and expected to grow at a CAGR of 10.5% due to high cancer treatment demand and strong infrastructure.
• Germany accounted for USD 18.22 Million in 2025 with a 7.3% share and is projected to grow at a CAGR of 11.2%, supported by advanced radiotherapy adoption.
• Japan captured USD 15.06 Million in 2025 with a 6% share, growing at a CAGR of 10.8% due to rising technological investments in oncology care.

Cushions

Cushions are essential accessories in patient positioning, offering comfort and stability during prolonged radiotherapy sessions. Approximately 40% of patients benefit from advanced cushion technologies, improving compliance and reducing treatment interruptions across multiple therapy cycles.

Cushions accounted for USD 59.14 Million in 2025, representing 23.8% of the market. This segment is projected to expand at a CAGR of 11.0% from 2025 to 2034, supported by growing emphasis on patient comfort and increased use in multi-session treatments.

Top 3 Major Dominant Countries in the Cushions Segment

• United States led the Cushions segment with a market size of USD 17.44 Million in 2025, holding a 7% share and expected to grow at a CAGR of 10.8% due to higher patient throughput in oncology centers.
• China accounted for USD 13.11 Million in 2025 with a 5.3% share, expanding at a CAGR of 11.5% fueled by growing cancer incidence and healthcare investments.
• France contributed USD 9.42 Million in 2025 with a 3.8% share, projected to grow at a CAGR of 10.9% due to modernization of radiotherapy clinics.

Thermoplastic Masks and Sheets

Thermoplastic masks and sheets play a critical role in immobilizing patients’ head and neck regions during targeted radiotherapy. Nearly 48% of radiotherapy treatments in oncology centers utilize thermoplastic masks to enhance precision in complex tumor sites.

Thermoplastic Masks and Sheets accounted for USD 68.07 Million in 2025, representing 27.4% of the market. This segment is anticipated to grow at a CAGR of 12.1% from 2025 to 2034, making it the fastest-growing segment due to increasing adoption in precision radiotherapy for head, neck, and brain cancers.

Top 3 Major Dominant Countries in the Thermoplastic Masks and Sheets Segment

• United States led the Thermoplastic Masks and Sheets segment with USD 20.43 Million in 2025, capturing an 8.2% share, projected to grow at a CAGR of 12.3% driven by advanced cancer treatment adoption.
• South Korea accounted for USD 12.68 Million in 2025 with a 5.1% share, growing at a CAGR of 12.6% due to rising preference for advanced immobilization devices.
• India reached USD 10.12 Million in 2025 with a 4.1% share, expanding at a CAGR of 12.7% with rapid healthcare infrastructure development.

Other Devices

Other positioning devices include wedges, bolus materials, and custom-made supports that complement standard immobilization tools. These devices account for about 25% of additional accessory usage, enhancing overall treatment accuracy and efficiency.

Other Devices accounted for USD 24.67 Million in 2025, representing 10% of the market. This segment is forecasted to grow at a CAGR of 10.4% from 2025 to 2034, driven by supportive use in diverse radiotherapy applications and increasing demand in developing regions.

Top 3 Major Dominant Countries in the Other Devices Segment

• United Kingdom led the Other Devices segment with a market size of USD 7.02 Million in 2025, holding a 2.8% share and expected to grow at a CAGR of 10.2% due to high adoption in public hospitals.
• Canada accounted for USD 6.11 Million in 2025 with a 2.5% share, expanding at a CAGR of 10.5% supported by modernized radiotherapy centers.
• Australia contributed USD 5.21 Million in 2025 with a 2.1% share, projected to grow at a CAGR of 10.6% owing to increasing patient safety focus.

By Application

Hospitals

Hospitals represent the largest application segment for radiotherapy patient positioning devices, with over 60% of global cancer treatments administered through hospital-based oncology departments. Nearly 58% of hospital facilities have integrated advanced positioning systems to improve treatment precision and patient safety, driving steady adoption worldwide.

Hospitals held the largest share in the radiotherapy patient positioning devices market, accounting for USD 138.17 Million in 2025, representing 55.6% of the total market. This segment is expected to grow at a CAGR of 11.3% from 2025 to 2034, driven by higher patient intake, technological integration, and infrastructure investments.

Top 3 Major Dominant Countries in the Hospitals Segment

• United States led the Hospitals segment with a market size of USD 42.64 Million in 2025, holding a 17.1% share and expected to grow at a CAGR of 11.2% due to advanced oncology infrastructure.
• Germany accounted for USD 23.29 Million in 2025 with a 9.4% share, projected to grow at a CAGR of 11.4% supported by universal healthcare adoption of radiotherapy devices.
• China contributed USD 20.11 Million in 2025 with an 8.1% share, expected to grow at a CAGR of 11.6% due to rapid hospital expansions.

Radiation Therapy Centers

Radiation therapy centers are specialized facilities focusing exclusively on radiotherapy treatments, contributing significantly to device adoption. About 32% of global patients prefer specialized centers for high-precision treatment, with 47% of centers implementing robotic and image-guided positioning devices.

Radiation Therapy Centers accounted for USD 86.95 Million in 2025, representing 35% of the total market. This segment is forecasted to grow at a CAGR of 11.4% from 2025 to 2034, driven by the demand for specialized care, increased patient preference, and advanced therapy systems.

Top 3 Major Dominant Countries in the Radiation Therapy Centers Segment

• United States led the Radiation Therapy Centers segment with USD 26.08 Million in 2025, holding a 10.5% share and projected to grow at a CAGR of 11.3% due to higher cancer caseloads and advanced therapies.
• Japan accounted for USD 18.22 Million in 2025 with a 7.3% share, expanding at a CAGR of 11.6% driven by precision oncology adoption.
• India contributed USD 12.44 Million in 2025 with a 5% share, forecasted to grow at a CAGR of 11.8% as specialized centers expand nationwide.

Other

Other applications include research institutions, private clinics, and small-scale oncology facilities where radiotherapy devices support diverse treatment approaches. Around 15% of these centers utilize customized positioning devices to support unique clinical setups and research-driven oncology treatments.

Other applications accounted for USD 23.30 Million in 2025, representing 9.4% of the total market. This segment is expected to expand at a CAGR of 10.9% from 2025 to 2034, driven by adoption in niche healthcare providers and research-focused oncology trials.

Top 3 Major Dominant Countries in the Other Applications Segment

• United Kingdom led the Other Applications segment with USD 6.29 Million in 2025, holding a 2.5% share and projected to grow at a CAGR of 10.8% due to strong public research institutions.
• Canada accounted for USD 5.11 Million in 2025 with a 2.1% share, growing at a CAGR of 11.0% supported by private oncology facility investments.
• Australia contributed USD 4.33 Million in 2025 with a 1.7% share, forecasted to grow at a CAGR of 10.9% due to research-led radiotherapy developments.

Radiotherapy Patient Positioning Devices Market Regional Outlook

The global radiotherapy patient positioning devices market was valued at USD 223.48 Million in 2024 and is projected to reach USD 248.42 Million in 2025, expanding further to USD 643.75 Million by 2034 with a CAGR of 11.16%. Regionally, North America accounted for 32%, Europe captured 25%, Asia-Pacific dominated with 30%, and the Middle East & Africa contributed 13% of the total market in 2025. Each region demonstrates unique adoption trends, shaped by healthcare investments, technological readiness, and cancer prevalence.

North America

North America dominates the market with 32% share in 2025, led by the United States where nearly 70% of oncology facilities use advanced immobilization and robotic positioning devices. Over 50% of cancer centers integrate thermoplastic masks for head and neck treatments, while 40% of hospitals adopt AI-assisted alignment solutions to minimize errors.

North America held the largest share in the radiotherapy patient positioning devices market, accounting for USD 79.49 Million in 2025, representing 32% of the total market. This segment is projected to expand significantly from 2025 to 2034, driven by higher treatment volumes, precision oncology, and technological adoption.

North America - Major Dominant Countries in the Market

• United States led North America with a market size of USD 42.85 Million in 2025, holding a 17.2% share due to strong oncology infrastructure and advanced device integration.
• Canada reached USD 21.25 Million in 2025 with an 8.6% share, supported by universal healthcare and growing adoption of positioning systems.
• Mexico recorded USD 15.39 Million in 2025 with a 6.2% share, driven by increasing investments in specialized radiotherapy centers.

Europe

Europe accounted for 25% of the market in 2025, supported by strong adoption across Germany, France, and the UK. Nearly 45% of radiotherapy centers use advanced immobilization cushions and 38% adopt robotic couches. Patient-centric initiatives and public health investments strengthen precision radiotherapy adoption across the region.

Europe accounted for USD 62.10 Million in 2025, representing 25% of the global market. This region is expected to show robust expansion, supported by research investments, increased cancer burden, and government healthcare policies enhancing device usage.

Europe - Major Dominant Countries in the Market

• Germany led Europe with a market size of USD 21.73 Million in 2025, holding an 8.7% share due to advanced radiotherapy adoption.
• France captured USD 20.12 Million in 2025 with an 8.1% share, supported by government healthcare reforms and facility expansions.
• United Kingdom recorded USD 20.25 Million in 2025 with an 8.2% share, boosted by NHS-led cancer care improvements.

Asia-Pacific

Asia-Pacific held a 30% market share in 2025, driven by high cancer incidence and strong infrastructure growth in China, Japan, and India. Over 52% of facilities in this region utilize thermoplastic masks, while nearly 48% deploy robotic or AI-driven systems for precision care.

Asia-Pacific reached USD 74.52 Million in 2025, representing 30% of the total market. This segment is anticipated to grow significantly by 2034, supported by rapid urbanization, higher healthcare budgets, and expanding specialized radiotherapy centers across emerging economies.

Asia-Pacific - Major Dominant Countries in the Market

• China led Asia-Pacific with a market size of USD 27.17 Million in 2025, holding a 10.9% share due to heavy healthcare investments and rising oncology treatments.
• Japan captured USD 23.41 Million in 2025 with a 9.4% share, driven by advanced cancer treatment protocols.
• India recorded USD 23.94 Million in 2025 with a 9.6% share, supported by rapid infrastructure growth and patient access initiatives.

Middle East & Africa

The Middle East & Africa accounted for 13% of the market in 2025, with demand primarily in Israel, UAE, and South Africa. Around 36% of facilities here have adopted robotic positioning systems, while 28% utilize advanced immobilization masks, reflecting rising healthcare modernization in oncology care.

Middle East & Africa represented USD 32.33 Million in 2025, accounting for 13% of the market. This region is forecasted to expand steadily by 2034, supported by investments in advanced oncology centers and collaborations with global medical device manufacturers.

Middle East & Africa - Major Dominant Countries in the Market

• Israel led with a market size of USD 12.17 Million in 2025, holding a 4.9% share, supported by high-end oncology care facilities.
• United Arab Emirates recorded USD 10.35 Million in 2025 with a 4.2% share, driven by rapid hospital expansion and private healthcare spending.
• South Africa contributed USD 9.81 Million in 2025 with a 3.9% share, reflecting increased cancer treatment capacity and public health investments.

List of Key Radiotherapy Patient Positioning Devices Market Companies Profiled

Investment Analysis and Opportunities in Radiotherapy Patient Positioning Devices Market

The radiotherapy patient positioning devices market is witnessing strong investment momentum, with nearly 42% of oncology-focused capital allocated toward advanced immobilization and robotic alignment solutions. Around 37% of funding is directed toward AI-based patient positioning to improve treatment accuracy and reduce radiation errors. Hospitals account for 55% of total investments, while 30% is funneled into radiation therapy centers upgrading infrastructure. Additionally, 28% of investors are targeting thermoplastic mask development due to rising demand in head and neck cancer treatments. With over 48% of emerging economies prioritizing radiotherapy infrastructure, significant opportunities exist for global players to expand into high-growth regions.

New Products Development

New product development in the radiotherapy patient positioning devices market is accelerating, with 33% of innovations focusing on thermoplastic masks for precision treatments. Nearly 40% of newly launched devices emphasize patient comfort through cushions and adaptive supports. Robotics-based alignment systems represent 29% of new product introductions, targeting enhanced accuracy in treatment delivery. Around 36% of research efforts concentrate on integrating imaging systems with positioning devices to improve real-time monitoring. Moreover, 31% of developments are aimed at eco-friendly and reusable positioning accessories to reduce waste in healthcare. This innovation-driven approach strengthens competitive advantage while meeting evolving oncology treatment needs.

Recent Developments

• Elekta launched AI-assisted positioning platforms: In 2024, Elekta introduced an AI-powered positioning system integrated with imaging, reducing alignment errors by nearly 28% and improving treatment accuracy for more than 40% of oncology patients worldwide.
• CIVCO Radiotherapy expanded thermoplastic mask portfolio: CIVCO added customizable thermoplastic masks offering 25% higher patient comfort and stability, adopted by 34% of cancer centers, especially for head and neck radiotherapy procedures.
• Orfit Industries unveiled eco-friendly immobilization devices: Orfit launched sustainable materials with 30% lower environmental impact, capturing 18% usage among hospitals aiming to reduce medical waste while maintaining treatment precision in radiotherapy.
• Klarity introduced hybrid cushion systems: Klarity rolled out cushions with adaptive technology, improving patient compliance by 22% and reducing repositioning needs by 15%, significantly enhancing throughput in radiation therapy centers.
• Qfix enhanced robotic couch solutions: Qfix upgraded its robotic couches with real-time imaging support, delivering 33% greater positioning precision and adopted in 26% of new oncology facility installations globally in 2024.

Report Coverage

The radiotherapy patient positioning devices market report provides an in-depth analysis of growth trends, segmentation, regional performance, and competitive landscape. The study covers key types such as immobilization systems, cushions, thermoplastic masks, and other devices, highlighting their adoption across hospitals and radiation therapy centers. In 2025, immobilization systems represented 38.8% of the market, while thermoplastic masks and sheets contributed 27.4%, reflecting strong demand for precision devices. Regionally, Asia-Pacific captured 30% share, North America 32%, Europe 25%, and the Middle East & Africa 13%, showing global diversification.

The report further evaluates opportunities, where 42% of investments are directed toward advanced positioning technologies, and 37% into AI-driven innovations. Challenges are also detailed, including high equipment costs that affect 40% of smaller facilities and a workforce shortage impacting 32% of treatment centers. Recent developments are analyzed, such as Elekta’s AI-assisted systems and Orfit’s eco-friendly devices, which together boosted innovation adoption by 28%. Additionally, the study profiles leading companies like CIVCO Radiotherapy, Klarity, Orfit Industries, and Elekta, which collectively hold more than 33% of the market share.

By combining segmentation, regional insights, and company strategies, the report ensures comprehensive coverage of drivers, restraints, challenges, and opportunities. It highlights that over 55% of hospitals prioritize investment in immobilization devices, while 48% of developing nations are accelerating infrastructure for radiotherapy. This extensive coverage provides stakeholders with valuable insights to make informed decisions and leverage high-growth opportunities in the global market.